Literature DB >> 9504689

bcl-6 protein is identified in high-grade but not low-grade mucosa-associated lymphoid tissue lymphomas of the stomach.

K Omonishi1, T Yoshino, I Sakuma, K Kobayashi, M Moriyama, T Akagi.   

Abstract

The pathogenesis of gastric mucosa-associated lymphoid tissue (MALT) lymphoma is an intriguing issue and is thought to be closely related to Helicobacter pylori infection. Gastric MALT lymphoma is thought to progress from the reactive state to low-grade malignancy and sometimes to high-grade malignancy. In the present study, we examined immunohistochemically the expression of bcl-6 and p53 proteins in gastric MALT and gastric diffuse large lymphoma without low-grade MALT lymphoma component (gastric DLL) to elucidate their role in high-grade transformation of low-grade MALT lymphoma. We detected bcl-6 protein only in the high-grade components in four of eight high-grade MALT lymphoma cases and in four of six gastric DLL cases. In contrast, none of 17 cases of low-grade MALT lymphoma expressed bcl-6 protein (P < .05). p53 protein was detected in the high-grade components in 6 of 8 high-grade MALT lymphoma cases and in 4 of 6 gastric DLL cases, but it was expressed in 2 of 17 cases of low-grade MALT lymphomas. All high-grade gastric MALT lymphomas cases were positive for p53 protein and/or bcl-6 protein. There is a tendency for an inverse relationship between bcl-6 protein and p53 protein. These findings suggest that high-grade transformation of gastric low-grade MALT lymphoma is associated with overexpression of p53 or bcl-6 protein.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9504689

Source DB:  PubMed          Journal:  Mod Pathol        ISSN: 0893-3952            Impact factor:   7.842


  9 in total

1.  Clinicopathological features of gastric mucosa associated lymphoid tissue (MALT) lymphomas: high grade transformation and comparison with diffuse large B cell lymphomas without MALT lymphoma features.

Authors:  T Yoshino; K Omonishi; K Kobayashi; T Mannami; H Okada; M Mizuno; I Yamadori; E Kondo; T Akagi
Journal:  J Clin Pathol       Date:  2000-03       Impact factor: 3.411

2.  Cavitary pulmonary involvement of diffuse large B-cell lymphoma transformed from extra nodal marginal zone B-cell lymphoma MALT type.

Authors:  Hiromichi Yamane; Masahiro Ohsawa; Yasuhiro Shiote; Shigeki Umemura; Toshimitsu Suwaki; Atsuko Shirakawa; Haruhito Kamei; Nagio Takigawa; Katsuyuki Kiura
Journal:  Clin J Gastroenterol       Date:  2011-10-04

3.  [Extranodal diffuse large B-cell lymphoma--an organotypic disease?].

Authors:  G Ott; A Rosenwald
Journal:  Pathologe       Date:  2007-02       Impact factor: 1.011

4.  Primary colorectal lymphoma comprising both components of diffuse large B-cell lymphoma and mucosa-associated lymphoid tissue lymphoma combined with cytomegalovirus colitis.

Authors:  Ryo Katsumata; Hiroshi Matsumoto; Osawa Motoyasu; Takahisa Murao; Manabu Ishii; Minoru Fujita; Hirotoshi Tokunaga; Takashi Akiyama; Hideho Wada; Takashi Sugihara; Akiko Shiotani; Ken Haruma
Journal:  Clin J Gastroenterol       Date:  2016-03-25

5.  Myc-mediated repression of microRNA-34a promotes high-grade transformation of B-cell lymphoma by dysregulation of FoxP1.

Authors:  Vanessa J Craig; Sergio B Cogliatti; Jochen Imig; Christoph Renner; Stefan Neuenschwander; Hubert Rehrauer; Ralph Schlapbach; Stephan Dirnhofer; Alexander Tzankov; Anne Müller
Journal:  Blood       Date:  2011-04-01       Impact factor: 22.113

6.  Prognostic value of cell-cycle markers in ocular adnexal lymphoma: an assessment of 230 cases.

Authors:  Sarah E Coupland; Martin Hellmich; Claudia Auw-Haedrich; William R Lee; Harald Stein
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2003-12-18       Impact factor: 3.117

7.  18q21 Rearrangement and trisomy 3 in extranodal B-cell lymphomas: a study using a fluorescent in situ hybridisation technique.

Authors:  Yan-Chin Tai; Jin-Ai Mary Anne Tan; Suat-Cheng Peh
Journal:  Virchows Arch       Date:  2004-09-09       Impact factor: 4.064

8.  The role of radiotherapy in the treatment of gastric mucosa-associated lymphoid tissue lymphoma.

Authors:  Taek-Keun Nam; Jae-Sook Ahn; Yoo-Duk Choi; Jae-Uk Jeong; Yong-Hyeob Kim; Mee Sun Yoon; Ju-Young Song; Sung-Ja Ahn; Woong-Ki Chung
Journal:  Cancer Res Treat       Date:  2014-01-15       Impact factor: 4.679

Review 9.  The Evolution in the Management of Gastric Lymphoma.

Authors:  Dana Hashim; Mariya Apostolova; Simon Lavotskin; Evan Goldstein; Mitchell Chorost
Journal:  Gastroenterology Res       Date:  2009-09-20
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.